HOME >> MEDICINE >> NEWS
Physicists set 'speed limit' for future superconducting magnet

EVANSTON, Ill. --- A research team led by a Northwestern University physicist has identified a high-temperature superconductor -- Bi-2212, a compound containing bismuth -- as a material that might be suitable for the new wires needed to one day build the most powerful superconducting magnet in the world, a 30 Tesla magnet.

The material currently used in magnetic resonance (MR) imaging machines in both hospitals and research laboratories -- a low-temperature superconducting alloy of the metallic element niobium -- has been pushed almost as far as it can go, to around 21 Tesla. (Tesla is used to define the intensity of the magnetic field.) There are no superconducting magnet wires currently available that can generate 30 Tesla.

"A new materials technology -- such as a technology based on high-temperature superconductivity -- is required to make the huge leap from 21 Tesla to 30 Tesla," said William P. Halperin, John Evans Professor of Physics and Astronomy in the Weinberg College of Arts and Sciences at Northwestern, who led the team. "We have shown that Bi-2212 could be operated at the same temperature as is presently the case for magnets made with niobium -- 4 degrees Kelvin -- and also achieve the stable state necessary for a 30 Tesla magnet."

The findings will be published online Feb. 11 by the journal Nature Physics.

"We are exploring nature's limitations, and our discovery has basic implications for the study of superconductors and for applications to magnetic resonance imaging," said Halperin. "The dream would be to have powerful magnets that don't require helium for cooling. Some day new materials might be discovered where this restriction is lifted, but it isn't possible at the present time."

A superconductor, when cooled to its appropriate temperature, conducts electricity without any resistance. Superconductivity first appears in Bi-2212 at a high temperature of 90 degrees Kelvin, but Halperin and his c
'"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
11-Feb-2007


Page: 1 2 3

Related medicine news :

1. Chaos=Order: Physicists make baffling discovery
2. 1 in 3 drivers under the limit for alcohol still test positive for drugs
3. NIH scientists target future pandemic strains of H5N1 avian influenza
4. The Eli and Edythe Broad Foundation invests in gastroenterologys future
5. The future of biofuels is not in corn
6. The future of biofuels is not in corn
7. Inactive kids storing up illness for the future
8. SCAIs Therapies in Evolution showcases exciting future of interventional cardiology
9. Conception date affects babys future academic achievement
10. ASU, Walter Reed researchers create prosthesis of the future
11. Why GNEP cant jump to the future

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Physicists set speed limit for future superconducting magnet

(Date:5/21/2013)... Today, Zane Benefits, Inc. published a ... accounts. Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution and http://HRA ... to Zane Benefits’ website, the Affordable Care Act (known ... in 2010 and impacts many areas of health care ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Two executives ... Guidance (SBG) will identify which strategies can be most ... high-quality care to the members who are taking them, ... Services, Inc., “How to Manage Specialty Drugs to ... pharmaceuticals are now the main driver for rising prescription ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 While North ... synonymous with comprehensive travel guides. Brunswick Plantation & Golf ... packages that include access to 27 holes of "Top10" ... courses in North Carolina, knowing the Top 10 ... Lodges takes away the overwhelming task of selecting the ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Octo ... technology and management consulting solutions to the Federal ... Business Development. In the newly created role, ... all aspects of the firm’s business development function ... proposal management functions, and leading strategies to achieve ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... therapy for patients having severe bouts of chronic obstructive ... days of glucocorticoid treatment with prednisone to treat COPD ... but with fewer chances for adverse side effects, they ... period of treatment was not less effective than 14 ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3
(Date:5/21/2013)... and TARRYTOWN, N.Y. , May 21, ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... online the positive Phase 2a study results of dupilumab ... an investigational monoclonal antibody targeting the alpha subunit of ... of both IL-4 and IL-13, drivers of Th2 (Type ...
(Date:5/21/2013)... Calif. , May 21, 2013 Abaxis, ... blood analysis systems, announced today that Martin ... at the Stifel Annual Dental & Veterinary Conference on ... conference will be held at Le Parker Meridien Hotel ... About Abaxis Abaxis develops, manufactures, markets ...
(Date:5/21/2013)... 2013 Reportlinker.com announces that a ... its catalogue:   ... Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario for ...   Summary ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
Cached News: